Trial intelligence / Profile preview

Melatonin and Metformin Loaded Nanoparticles in the Treatment of Periodontal Intra-bony Defects

NCT05906563Phase 2Unknown

Start
Dec 2022
Primary completion
May 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Mucomel, metformin 1% gel in periodontal disease. Status: unknown.

02

Drugs

Mucomelmetformin 1% gel
03

Conditions

periodontal disease

Beyond the preview

Go deeper on NCT05906563.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05906563.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call